Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.38
Delayed Data
As of May 26
 -0.17 / -2.25%
Today’s Change
6.90
Today|||52-Week Range
9.88
-13.89%
Year-to-Date
No recent news for Neogenomics Inc.

Today’s Trading

Previous close7.55
Today’s open7.50
Day’s range7.33 - 7.51
Volume171,836
Average volume (3 months)334,949
Market cap$584.8M
Dividend yield--
Data as of 05/26/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)+18.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book3.54

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.11+1.07%
ENZEnzo Biochem Inc+0.03+0.33%
NVTAInvitae Corp+0.18+2.14%
RDNTRadNet Inc0.000.00%
Data as of 05/26/2017

Financials

Next reporting dateJuly 20, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts